Type I interferons in tuberculosis: Foe and occasionally friend

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Tuberculosis (TB) is a major global health threat caused by Mycobacterium tuberculosis.
• Type I interferons (IFN-I) are crucial immune regulators with known antiviral activity.
• The role of IFN-I in TB pathogenesis is complex and debated, with evidence suggesting both detrimental and protective effects.

Purpose of the Study:

• To elucidate the mechanistic and contextual factors governing the dual role of Type I interferons in tuberculosis.
• To reconcile conflicting findings regarding IFN-I's impact on Mycobacterium tuberculosis infection.

Main Methods:

• Review and synthesis of existing human and experimental mouse model data on IFN-I in TB.
• Analysis of transcriptional studies and immunological responses during M. tuberculosis infection.

Main Results:

• Evidence indicates Type I IFN can promote M. tuberculosis bacterial expansion and disease progression.
• Contrasting studies suggest a potential protective role for Type I IFN in certain contexts.
• Mechanistic and contextual factors are key to understanding IFN-I's dichotomous effects.

Conclusions:

• The outcome of Type I IFN induction in tuberculosis is highly dependent on specific conditions and host-pathogen interactions.
• Further research is needed to fully understand and potentially harness IFN-I for TB treatment.